NK-cell lymphoma
Clinical trials for NK-cell lymphoma explained in plain language.
Never miss a new study
Get alerted when new NK-cell lymphoma trials appear
Sign up with your email to follow new studies for NK-cell lymphoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a powerful combo of drugs and stem cell transplant beat tough lymphomas in kids?
Cure Recruiting nowThis trial is testing a two-step approach for children, teens, and young adults with advanced T-cell or NK-cell lymphoma or leukemia. First, patients receive a combination of chemotherapy and immunotherapy drugs to shrink the cancer. Then, those who respond go on to receive a ste…
Matched conditions: NK-CELL LYMPHOMA
Early phase 1 • Sponsor: New York Medical College • Aim: Cure
Last updated Aug 20, 2026 00:00 UTC
-
New hope for rare lymphomas: drug that blocks JAK protein under study
Disease control Recruiting nowThis study tests the drug ruxolitinib in people with T or NK cell lymphoma that has come back or not responded to prior treatment. Ruxolitinib works by blocking a protein called JAK, which helps these cancer cells survive. The goal is to see if the drug can shrink tumors or contr…
Matched conditions: NK-CELL LYMPHOMA
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Massive T-Cell lymphoma database aims to unlock new insights
Knowledge-focused Recruiting nowThis study is creating a large database of information and tissue samples from 1,000 people with T-cell lymphoma. Researchers will use this data to learn more about the disease and how to improve patient outcomes. Participants provide medical information and optional blood and na…
Matched conditions: NK-CELL LYMPHOMA
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC